Drug Discovery - Event guide: 11th 3D Tissue Models Summit 2026
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Vibration Isolation System Design for Cancer Research Facility at Oregon Health and Science UniversityVibration Isolation System Design for Cancer Research Facility at Oregon Health and Science University

Dr. Joe Gray of OHSU discusses how vibration isolation enables high‑resolution, long‑duration cancer research imaging. He explains the need for nanometer‑level stability, challenges posed by Portland’s vibration‑prone environment, and how advanced damping technologies support studying cancer cell structure and developing better treatment strategies.

Access Interview Now
 
 
    Event guide: 11th 3D Tissue Models Summit 2026Event guide: 11th 3D Tissue Models Summit 2026
 
Dedicated to advancing physiologically relevant in vitro models, the 11th 3D Tissue Models Summit 2026 brings together leaders in organoids, spheroids, and complex co-culture systems.
 
Get the Guide
 
 
   Digital Twins in Precision Medicine and Drug DiscoveryDigital Twins in Precision Medicine and Drug Discovery
 
Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.
 
 Overcoming Endosomal Escape in Oligonucleotide Drug Delivery
 
Overcoming Endosomal Escape in Oligonucleotide Drug DeliveryThis study addresses endosomal escape in oligonucleotide therapies and how engineered peptides can enhance intracellular drug delivery efficiency.
 
 
 Can Quantum Computing Reduce the Cost of Failed Drug Candidates?
 
Can Quantum Computing Reduce the Cost of Failed Drug Candidates?With its ability to enhance predictive accuracy, quantum computing may significantly lower R&D costs in pharmaceuticals by reducing candidate failures.
 
 
 Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
 
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteinsNuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific partnership.
 
 
 AI model accelerates antibody production and clone selection
 
AI model accelerates antibody production and clone selectionAs instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026